Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Amyris Completes Sale of Vitamin E Royalty to DSM - Happi
Company News, Financial News

Amyris Completes Sale of Vitamin E Royalty to DSM

Move simplifies Amyris and improves predictability.

Amyris, Inc. has sold its vitamin E royalty agreement to Koninklijke DSM NV (Royal DSM). The move assigns Amyris’s rights to vitamin E royalties to DSM in exchange for total consideration of approximately $57 million. In addition, DSM and Amyris have agreed to a further manufacturing cooperation for Amyris products at DSM’s Brotas facility that provides additional capacity and lower cost of goods sold with an expected approximate aggregate benefit of $30–$40 million during the next three years. The expected economic benefit of both agreements to Amyris is approximately $90 million.


As a result of this agreement, Amyris has now fully exited the vitamin E business and is focused on driving commercial growth in its major markets: flavor and fragrance ingredients, skin care, sweetener, and most recently, cannabinoids. According to the company, these are markets where Amyris is demonstrating market leadership with its products, brands and resulting underlying growth and margin.


“We are pleased to have executed this agreement in the timeframe expected and to have secured lower-cost manufacturing while we seek to bring our own production facility online in 2020,” said John Melo, president and CEO of Amyris. “As we said, the economics of this agreement are superior to those offered under the deal we elected to forego, and ensure our ability to deliver continuous supply to our customers at a competitive cost.”


Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters